Open AccessSubcutaneous Epcoritamab for B-Cell Non-Hodgkin Lymphoma
Author(s) -
Catlin Nalley
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000791836.96923.d3
Subject(s) - medicine , lymphoma , cd20 , cytokine release syndrome , dosing , refractory (planetary science) , monoclonal antibody , oncology , antibody , chemotherapy , immunology , cancer , immunotherapy , chimeric antigen receptor , biology , astrobiology